{"version":"1.0","provider_name":"thesmartcityjournal.com","provider_url":"https:\/\/www.thesmartcityjournal.com\/en","title":"Aspirin cuts liver fat in trial - thesmartcityjournal.com","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"8RKH7OQpsG\"><a href=\"https:\/\/www.thesmartcityjournal.com\/en\/biotechnology\/aspirin-cuts-liver-fat-in-trial\">Aspirin cuts liver fat in trial<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.thesmartcityjournal.com\/en\/biotechnology\/aspirin-cuts-liver-fat-in-trial\/embed#?secret=8RKH7OQpsG\" width=\"600\" height=\"338\" title=\"&#8220;Aspirin cuts liver fat in trial&#8221; &#8212; thesmartcityjournal.com\" data-secret=\"8RKH7OQpsG\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.thesmartcityjournal.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/www.thesmartcityjournal.com\/wp-content\/uploads\/2024\/03\/Aspirin.jpg","thumbnail_width":1280,"thumbnail_height":800,"description":"The most common chronic liver disease \u2014 metabolic dysfunction\u2013associated steatotic liver disease (MASLD) \u2014 is characterized by an increased buildup of fat in the liver due to factors such as obesity and Type 2 diabetes. Such elevated fat poses serious health risks, but a recent clinical trial published in JAMA and conducted by investigators from Massachusetts General Hospital points to a possible treatment: aspirin. \u201cSince MASLD is estimated to affect up to a third of U.S. adults, aspirin represents a"}